-
Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child
Sep 9, 2025, 16:22 PM -
Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval
Sep 9, 2025, 16:22 PM -
A Nutrient-Dense Formula in Undernourished Children in Indonesia: An Effective Cost-Saving Strategy
Sep 9, 2025, 16:22 PM -
Socioeconomic Disparities in Postpartum Depression Following Abortion Restrictions: A Difference-in-Differences Analysis of Medicaid Data Post-Dobbs
Sep 9, 2025, 16:22 PM -
Decoding Diagnosis Delay in Juvenile Idiopathic Arthritis (JIA)
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review and Meta-Analysis Comparing Robotic-Assisted Mitral Valve Repair Using the Da Vinci Surgical System to Open Mitral Valve Repair
Sep 9, 2025, 16:22 PM -
Impact of Delayed or Missing Diagnosis of Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
Balancing Rigor and Feasibility of Real-World Data Demands in Germany Within the EU HTA Context: How Fit for Purpose Is the Routine Practice Data Collection (Anwendungsbegleitende Datenerhebung, AbD)?
Sep 9, 2025, 16:22 PM -
Real-World Insights Into Prostate Cancer Management Using Electronic Health Record-Derived Data From the UK
Sep 9, 2025, 16:22 PM -
Value Framework to Support Payer Decisions in Hemophilia in Türkiye
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Systemic Therapies in Adults with KRAS(G12C) Metastatic Colorectal Cancer in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling
Sep 9, 2025, 16:22 PM -
Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?
Sep 9, 2025, 16:22 PM -
Broader Economic Effects of Investment in Cancer Control in Commonwealth Countries
Sep 9, 2025, 16:22 PM -
Are Real-World Survival Outcomes in Metastatic Breast Cancer Transportable Between the US and Austria?
Sep 9, 2025, 16:22 PM -
Real-World Outcomes and Economic Impact of Ribociclib in HR+/HER2- Advanced Breast Cancer: Evidence From the Portuguese REASSURE Cohort
Sep 9, 2025, 16:22 PM -
Caregiver QALYs Deserve Better: Why It's Time for a Methodological Rethink
Sep 9, 2025, 16:22 PM -
Relationship Between Cost-Effectiveness Threshold and Drug Reimbursement in Spain, Italy, and France
Sep 9, 2025, 16:22 PM -
The Cost of Inaction: Strengthening Nutrition in Frailty Guidelines Across Europe
Sep 9, 2025, 16:22 PM -
Efficient and High-Quality Decision Making: An Exploration of Disease-Specific Reference Models at NICE
Sep 9, 2025, 16:22 PM
